Meme Scholar with Madness (PhD)

[EndtheMadnessNow]

News from 100 years ago...

March 26, 1925: Edna Osborne, a 15-year-old who is the only known school-age child in New York City to refuse vaccination, does not have to get her shots, a court rules. However, her mother, Sarah, will be responsible for homeschooling her.




March 26, 1925: Tattoo Craze Hits D.C. Women
"According to certain so-called scientific gentlemen opposed to vaccinations against smallpox, tattooing and vaccination may, as it were, be pitted against one another."




March 26, 1925: Sec of the Treasury Mellon setting fire to the $5,000 note of the National Press Club at the "Mortgage Burning" party.




March 26, 1925: Australian Railways Minister Richard T. Ball helps lay the southern foundation stone for what will be the Sydney Harbor Bridge, watched by a large crowd. Bridge construction started on July 28, 1923. Bridge opened March 19, 1932.


The bridge is held together by six million Australian-made hand-driven rivets supplied by the McPherson company of Melbourne, the last being driven through the deck on 21 January 1932. The rivets were heated red-hot and inserted into the plates; the headless end was immediately rounded over with a large pneumatic rivet gun. The largest of the rivets used weighed 3.5 kg (8 lb) and was 39.5 cm (15.6 in) long. The practice of riveting large steel structures, rather than welding, was, at the time, a proven and understood construction technique, whilst structural welding had not at that stage been adequately developed for use on the bridge.


March 26, 1942: the light cruiser HMS Penelope (97) was damaged in air attacks on Malta. Over the next several days, subsequent air attacks put so many holes in the ship that she was nicknamed "HMS Pepperpot". After the holes were plugged with long pieces of wood, she became "HMS Porcupine".


She was torpedoed twice and sunk by the German U-boat U-410 near Naples on February 18, 1944. 417 of the crew, including the captain, went down with the ship, with only 206 survivors.


March 26, 1951: Robert J. Hooker delivered a memorandum on the Troy Report..."almost uniformly reflects a very high order of technical competence, political sophistication, and common sense. It deserves the most serious consideration. It lays down principles and techniques for the conduct of political warfare which, with few exceptions, seem worthy of adoption." Project Troy was a research study of psychological warfare undertaken for the Department of State.




Guinness - Surfer (1999, UK) One of the greatest ads ever.



Jonathan Glazer: Making of Guinness 'Surfer' *rare color footage*
https://www.youtube.com/watch?v=bO4bA_RPi7s


Neptune's Horses, 1892 by Walter Crane.




Melania & Barron Trump for a photo shoot at the Mar-a-Lago Club on March 26, 2011. Barron's clothes by Bonpoint.




Over the top Obit...



Richard Warner Carlson, a prominent American journalist, diplomat, and lobbyist who played a pivotal role during the last six years of the Cold War. Carlson's impressive career spanned across various media outlets, and he was a prominent figure in the broadcasting world, particularly in Radio Marti broadcasting to Cuba.The video takes us through Carlson's journey, from his early beginnings as a journalist, to his appointment as the Director of the Voice of America (VOA) in 1982, a position he held until 1988.

Who is Dick Carlson?
https://www.youtube.com/live/14JJJBiUKtY

Dick Carlson, Reports on the Zodiac Killer's Murder of Paul Stine (1969):
https://www.youtube.com/watch?v=erj4tlPB_O8


Interesting to note that national security adviser Mike Waltz is the brother-in-law of Scott Stapp, lead singer of Creed. Waltz could possibly redeem himself by arranging for Creed to headline Americas 250th birthday. LOL. Imagine Trump walking out to...




I (and many others) were highly skeptical of this company 5 years ago. A front for something else. A few years ago they had sold a portion of their DNA bank to big pharma when they previously told their customers they would not do that.


Welp, too late for that. It's already been off-shored and or China has it by now.

23andMe files for Chapter 11 bankruptcy as co-founder and CEO Wojcicki resigns

From $6 billion unicorn to bankrupt cautionary tale: The story of 23andMe

Here’s a timeline of events that shaped 23andMe trajectory:

2006: Linda Avey, a genetics expert, Paul Cusenza, an engineer and executive, and Anne Wojcicki, a former healthcare investments analyst, launch 23andMe. Avey had previously conceived of the idea and pitched it to investors, including Google’s cofounders. According to Avey, Sergey Brin suggested Wojcicki become a cofounder. (Brin and Wojcicki were married at the time.)

2007: 23andMe initially begins offering DNA tests for $1,000 per order, asking customers to send their spit to the company in a vial in exchange for information about their ancestry and some health risks. The company’s test allows users to opt in to share their data with researchers and answer questions about their lifestyle, creating a potentially valuable database for future mining. New York Times journalist Amy Harmon writes an in-depth personal account of testing her DNA with 23andMe, bringing widespread awareness of the company and its potential. The company also becomes known for celebrity-attended “spit parties.”

2009: Wojcicki and the board announce Linda Avey is leaving the company. (Cusenza had left in 2008.) Years later, Avey tells the podcast She Leads: “It’s not something I chose.” She also calls the ouster “devastating.”

November 22, 2013: The FDA sends Wojcicki a warning letter over its spit kit tests that offer customers health and disease risk information. The company takes its health results products off the market and hires experts to navigate regulatory affairs. Two years later, the FDA approves 23andMe’s consumer-focused genomic health tests, creating a first-of-its-kind FDA-approved product.

March 12, 2015: Wojcicki launches a drug discovery business, looking to capitalize on the data it has collected from consumers. This leads the company into a costly undertaking, with Wojcicki later recounting how she was warned against doing drug research, which can cost hundreds of millions of dollars, require several years, and doesn’t guarantee success. Wojcicki recruits top scientific researchers and 23andMe eventually develops two cancer drug targets that will reach clinical phase trials.

July 25, 2018: GSK signs a deal with 23andMe that gives the drug company exclusive access to 23andMe’s database—including DNA data for it’s then-5 million customers—for four years. “The goal of the collaboration is to gather insights and discover novel drug targets driving disease progression and develop therapies for serious unmet medical needs based on those discoveries,” GSK says in a press release. This partnership will later be extended until 2025 and GSK will announce that it led to potentially viable drug targets.

June 16, 2021: 23andMe goes public via a Richard Branson and Virgin Group—backed SPAC deal. The listing briefly values the company at $6 billion, but it will be worth $3 billion by the end of the year.

November 1, 2021: 23andMe buys telehealth company Lemonaid Health for $400 million. It was always Wojcicki’s goal for 23andMe to offer retail DNA testing, run drug research, and integrate genomic testing and clinical medicine.

October 6, 2023: A major data breach exposes the DNA of 6.9 million people targeted by hackers. The company later confirms that the hackers targeted customers of Ashkenazi Jewish and Chinese ancestry. The breach also leads to a class-action lawsuit that will force the company to pay a $30 million settlement in 2024.

January 31, 2024: The Wall Street Journal publishes an explosive story looking at the reasons 23andMe’s was trading as a penny stock and has never turned a profit. As a public company, major flaws in its business model become obvious. Sources in the story question whether Wojcicki is paying enough attention to the company’s fundamentals or if she’s building a personal brand. More broadly, the biotech market is also suffering from a downturn that began in 2022.

April 18, 2024: With 23andMe financials still deteriorating, Wojcicki expresses interest in taking the company private. As the controlling shareholder, she also says she will not be open to outside bids. (She changes her stance a few times months later.) The 23andMe board forms a special committee to prepare to assess a deal.

August 2, 2024: The board responds to Wojcicki’s first bid to take the company private for 40 cents per share. It does not believe the share price is appropriate and it is unhappy with the dearth of details about financing the sale. “Our expectation after months of work was that you would submit a fully-financed, fully-diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders,” the board writes. It also offers the opportunity to resubmit the proposal at a later date. The company extends this deadline again when Wojcicki’s sister, Susan Wojcicki, the CEO of YouTube, dies of lung cancer.

September 18, 2024: In a shocking turn, the entire board of 23andMe resigns on the same day, explaining in a public letter that its members felt they had few other options. Wojcicki, as the controlling shareholder, had said she would not entertain other offers and the board had not received an improved bid while the company was facing dire straits. The group—which included luminaries such as Neal Mohan, CEO of YouTube, and Roelof Botha, head of Sequoia Capital—wrote that while they “wholeheartedly” believed in the company’s mission to personalize health care with genetic data, they disagreed with Wojcicki’s strategic direction.

October 16, 2024: 23andMe completes a reverse stock split to avoid being delisted from NASDAQ. The share price had previously fallen below $1.

October 17, 2024: Wojcicki tells Fortune in her first public interview since the board’s resignation that she still believes she “can land this plane” and that she was as surprised as anyone about the board’s resignation. She also responds to former employees’ suggestions that her overly-controlling leadership style helped to sink the company. “I’ve always said ever since the very beginning, I don’t need to be in charge,” she told Fortune. “There’s no ego for me. I care about the vision and the mission.”

February 20, 2025: After closing the drug discovery business, laying off nearly half of 23andMe’s staff, and adding three CFOs to her new board, Wojcicki links up with New Mountain Capital and submits a new proposal to buy 23andMe that values the company at $75 million. Nervous retail investors tell Fortune they hope the board will not accept her first offer.

March 2, 2025: Wojcicki explains in a new public filing that New Mountain Capital is “no longer interested” in partnering with her on the proposal. Wojcicki includes a new bid, this time valuing the company at $42 million. The board rejects that proposal later the same day.

March 24, 2025: 23andMe announces it’s entering bankruptcy, prompting data privacy concerns. Anne Wojcicki steps down as CEO but says she will still make yet another bid to buy the company. “Consumers are rising up and asking for more control over their health and want greater knowledge about how to be healthy and why they may have health issues,” she writes on X.com. “We fought for consumers to have direct access to their information and for them to have choice and transparency with respect to their personal data. As I think about the future, I will continue to tirelessly advocate for customers to have choice and transparency with respect to their personal data, regardless of platform.”

Correction: This story has been updated to reflect the correct year that the FDA sent 23andMe a warning letter about its DNA tests with health risk results.